IRVINE, Calif., Nov. 04, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that its Chief Executive Officer and Founder, Frank Jaksch, will attend the Torrey Hills Capital 2 nd Annual Emerging Growth Conference. The investor conference will be held on Nov. 10-12, 2016 at the Hilton Del Mar in Del Mar, California. Mr. Jaksch is scheduled to attend one-on-one meetings on Nov. 11, 2016 with investment professionals throughout the day. About ChromaDex:ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals (known as "phytochemicals"), chemistry and analytical testing services, and product regulatory and safety consulting (known as Spherix Consulting). As a result of our relationships with leading universities and research institutions, we are able to discover and license early stage, IP-backed ingredient technologies. We then utilize our in-house chemistry, regulatory and safety consulting business units to develop commercially viable ingredients. Our ingredient portfolio is backed with clinical and scientific research, as well as extensive IP protection. Our portfolio of patented ingredient technologies includes NIAGEN ® nicotinamide riboside; pTeroPure ® pterostilbene; PURENERGY ® , a caffeine-pTeroPure ® co-crystal; IMMULINA ™, a spirulina extract; and AnthOrigin ™, anthocyanins derived from a domestically-produced, water-extracted purple corn. To learn more about ChromaDex, please visit www.ChromaDex.com.